Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Masanari Mizuta"'
Autor:
Daisuke Hidaka, Masanari Mizuta, Hiroka Sano, Sakura Nakatani, Kuniya Isobe, Yuki Narita, Sumio Hirata, Michiko Kawakami
Publikováno v:
International journal of clinical pharmacology and therapeutics. 57(5)
AIMS Serum creatinine (Cr)-derived estimated renal function indices are overestimated in elderly patients with reduced muscle mass (MM). We sought to identify equations correlated with measured glomerular filtration rate (mGFR) and assess the effect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b1f1a0c081b88696fae6648f052e623
https://pubmed.ncbi.nlm.nih.gov/30704556
https://pubmed.ncbi.nlm.nih.gov/30704556
Autor:
Wakaba Tsuchimochi, Masanari Mizuta, Hiroaki Ueno, Noboru Nakashima, Kenji Noma, Mitsuteru Fujihara, Masamitsu Nakazato, Tomomi Shiiya
Publikováno v:
Diabetes Care. 37:2024-2027
OBJECTIVE This study aimed to assess the efficacy and safety of our newly developed nasal glucagon-like peptide-1 (GLP-1) compound and injector. RESEARCH DESIGN AND METHODS Twenty-six patients with type 2 diabetes were enrolled in this double-blind p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42be8a431c3b8cb19864b6287cca26c7
https://doi.org/10.2337/dc13-0690
https://doi.org/10.2337/dc13-0690
Autor:
Shinichi Mashiba, Masamitsu Nakazato, Yukie Saitoh, Shiho Kojima, Tomomi Shiiya, Kenji Noma, Masanari Mizuta, Hiroaki Ueno
Publikováno v:
Obesity Research & Clinical Practice. 5:e335-e340
Summary Objective The benefits of fenofibrate, a peroxisome proliferator-activated receptor α agonist, against cardiovascular risk factors have been established. To clarify the underlying mechanisms of these benefits, we examined the effects of feno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51452fc49435def427c91e9f91c4bcad
https://doi.org/10.1016/j.orcp.2011.03.012
https://doi.org/10.1016/j.orcp.2011.03.012
Publikováno v:
Metabolism. 60:1081-1089
Glucagon-like peptide-1 (GLP-1) and angiotensin II type 1 receptor blocker reduce β-cell apoptosis in diabetes, but the underlying mechanisms are not fully understood. We examined the combination effects of GLP-1 and candesartan, an angiotensin II t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7f70171ff762643794d35ac74003d48
https://doi.org/10.1016/j.metabol.2010.11.004
https://doi.org/10.1016/j.metabol.2010.11.004
Publikováno v:
Diabetes Research and Clinical Practice. 90:54-59
Angiotensin II receptor blockers (ARBs) have been shown to decrease insulin resistance in obese diabetic animal models and reduce the risk of new-onset diabetes in hypertensive patients. In the present study, we studied whether candesartan, an ARB, c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6316f8c50fcc3160bc267f10b865066
https://doi.org/10.1016/j.diabres.2010.06.005
https://doi.org/10.1016/j.diabres.2010.06.005
Publikováno v:
Endocrine Journal. 54:895-902
Ghrelin is an acylated 28-amino-acid peptide that stimulates food intake, GH secretion, and gastric motility. Experimental studies have suggested that ghrelin plays roles in glucose homeostasis, atherosclerosis, and microangiopathy. We investigated p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e18f79bcaaf7c5d0661a77fd0f767661
https://doi.org/10.1507/endocrj.k07-007
https://doi.org/10.1507/endocrj.k07-007
Autor:
Masanari Mizuta
Publikováno v:
Folia Pharmacologica Japonica. 125:125-128
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7fc50e28a1c5d9d38bb479983b05841b
https://doi.org/10.1254/fpj.125.125
https://doi.org/10.1254/fpj.125.125
Publikováno v:
European Journal of Pharmacology. 458:227-234
This study aimed to investigate the effect of long-term oral nicotine administration on insulin resistance in an animal model of obesity. Eight-week-old male Zucker fatty rats (ZFRs) were administered nicotine tartrate dihydrate (4.6 mg/kg/day) in th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::785316c9e66c0e5d2fa1459e58990714
https://doi.org/10.1016/s0014-2999(02)02726-7
https://doi.org/10.1016/s0014-2999(02)02726-7
Publikováno v:
International Journal of Obesity. 26:318-326
AIM: To clarify the mechanism by which insulin resistance develops in obesity, Zucker fatty rats (ZFR) and lean litter mates (ZLR) were temporally subjected to oral glucose tolerance tests (OGTT) at 6 and 15 weeks of age. METHOD: As candidates for ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::184f9cbd22001bf372f153341ad014cc
https://doi.org/10.1038/sj.ijo.0801924
https://doi.org/10.1038/sj.ijo.0801924
Autor:
Masamitsu Nakazato, Muhtashan S. Mondal, Yukari Date, Shin-ichi Nozoe, Tomomi Shiiya, Masanari Mizuta, Shigeru Matsukura, Hiroshi Hosoda, Kenji Kangawa, Muneki Tanaka
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 87:240-244
Ghrelin, a novel GH-releasing peptide isolated from human and rat stomach, stimulates food intake and GH secretion. We determined plasma ghrelin concentrations in patients with simple obesity, anorexia nervosa, and type 2 diabetes mellitus by RIA. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d58c314158cdfcfffda8fc38f0b85668
https://doi.org/10.1210/jcem.87.1.8129
https://doi.org/10.1210/jcem.87.1.8129